http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0259519-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 1988-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffedf2a591c7e6d7331656e47805c6ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6e2d372956a3cfe493e44964014a298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a1c4f57c7cdc262a47fd6bd21d0485d
publicationDate 1990-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0259519-A
titleOfInvention Remedy for skin inflammation
abstract PURPOSE: To obtain a remedy for skin inflammation having slight irritation and excellent stability comprising ubidecarenone as an active ingredient. n CONSTITUTION: The aimed substance is obtained by blending 0.05-5%, preferably 0.1-2% ubidecarenone as an active ingredient with glycerin, squalane, cetyl alcohol, egg yolk phospholipid, glyceryl fatty acid ester, etc., and pharmaceutically manufacturing by a conventional procedure for skin administration. Ubidecarenone is extracted from mitochondria of bovine cardiac muscle, has 48-52°C melting point, is yellow-orange crystalline powder, fat-soluble and hardly soluble in water and methanol. The aimed substance can be processed into a form such as into cream, milky lotion or ointment. The aimed substance has excellent effects on dermatitis, especially on acute inflammation. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008031110-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008111384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0185156-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0719552-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001089320-A
priorityDate 1988-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57501260
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226489190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 39.